FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Teresa Hill

Research Profile

Disorders

HIV Infections

Procedures

Concepts & Ideas

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
D Dolling; David Dunn; E Fearnhill; Teresa Hill; Andrew N Phillips; Deenan Pillay; J Shepherd; P A Cane; A M Crook; Valerie Delpech
Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with men.
Mark Gompels; Teresa Hill; Margaret Johnson; Clifford Leen; Chloe Orkin; Andrew Phillips; Deenan Pillay; Frank Post; Caroline Sabin; John Walsh; Jonathan Ainsworth; Jane Anderson; Loveleen Bansi; Andrew De Burgh Thomas; Debbie Dooley; David T Dunn; Philippa Easterbrook; Martin Fisher; Brian Gazzard; Richard Gilson
Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy?
Susie E Huntington; Marie-Louise Newell; Deenan Pillay; Caroline A Sabin; Graham P Taylor; Claire Thorne; Pat A Tookey; Jane Anderson; Loveleen K Bansi; Teresa Hill
Using two on-going HIV studies to obtain clinical data from before, during and after pregnancy for HIV-positive women.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Teresa Hill (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: D Dolling; David Dunn; E Fearnhill; Teresa Hill; Andrew N Phillips; Deenan Pillay; J Shepherd; P A Cane; A M Crook; Valerie Delpech
Evaluating the extent of potential resistance to pre-exposure prophylaxis within the UK HIV-1-infectious population of men who have sex with men.
HIV medicine 2012;13(5):309-14.
2012: Mark Gompels; Teresa Hill; Margaret Johnson; Clifford Leen; Chloe Orkin; Andrew Phillips; Deenan Pillay; Frank Post; Caroline Sabin; John Walsh; Jonathan Ainsworth; Jane Anderson; Loveleen Bansi; Andrew De Burgh Thomas; Debbie Dooley; David T Dunn; Philippa Easterbrook; Martin Fisher; Brian Gazzard; Richard Gilson
Does discordancy between the CD4 count and CD4 percentage in HIV-positive individuals influence outcomes on highly active antiretroviral therapy?
The Journal of infectious diseases 2012;205(4):540-7.
2012: Susie E Huntington; Marie-Louise Newell; Deenan Pillay; Caroline A Sabin; Graham P Taylor; Claire Thorne; Pat A Tookey; Jane Anderson; Loveleen K Bansi; Teresa Hill
Using two on-going HIV studies to obtain clinical data from before, during and after pregnancy for HIV-positive women.
BMC medical research methodology 2012;12():110.
2012: C Kober; Clifford Leen; Chloe Orkin; Adrian Palfreeman; Andrew N Phillips; F Post; Caroline A Sabin; John Walsh; J Ainsworth; Jane Anderson; L Bansi; Valerie Delpech; D Dunn; Martin Fisher; Brian Gazzard; Richard Gilson; M Gompels; Teresa Hill; Margaret Johnson
Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UK.
HIV medicine 2012;13(1):73-8.
2011: R A Hughes; M A Johnson; Clifford Leen; Chloe Orkin; Andrew N Phillips; Deenan Pillay; J A C Sterne; John Walsh; J Ainsworth; Jane Anderson; L Bansi; D Dunn; Philippa Easterbrook; Martin Fisher; Brian Gazzard; Richard Gilson; M Gompels; Teresa Hill; Caroline A Sabin
Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study.
HIV medicine 2011;12(10):583-93.
2011: Lucy Garvey; Alan Winston; John Walsh; Frank Post; Kholoud Porter; Brian Gazzard; Martin Fisher; Clifford Leen; Deenan Pillay; Teresa Hill; Margaret Johnson; Richard Gilson; Jane Anderson; Philippa Easterbrook; Loveleen Bansi; Chloe Orkin; Jonathan Ainsworth; Andrew N Phillips; Caroline A Sabin
HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2011;18(3):527-34.
2011: Margaret May; Mark Nelson; Chloe Orkin; Adrian Palfreeman; Andrew Phillips; Kholoud Porter; Frank Post; Jonathan Ainsworth; Jane Anderson; Loveleen Bansi; Valerie Delpech; David Dunn; Martin Fisher; Brian Gazzard; Richard Gilson; Mark Gompels; Teresa Hill; Margaret Johnson; Clifford Leen; John Walsh; Caroline Sabin
Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.
BMJ (Clinical research ed.) 2011;343():d6016.
2011: Tristan J Barber; Valerie Delpech; David Dunn; Philippa Easterbrook; Martin Fisher; Brian Gazzard; Anna Maria Geretti; Richard Gilson; Mark Gompels; Teresa Hill; Margaret Johnson; Clifford Leen; Chloe Orkin; Adrian Palfreeman; Andrew N Phillips; Deenan Pillay; Frank Post; Caroline A Sabin; Achim Schwenk; John Walsh; Jane Anderson; Loveleen Bansi
Outcomes in the first year after initiation of first-line HAART among heterosexual men and women in the UK CHIC Study.
Antiviral therapy 2011;16(6):805-14.
2010: Teresa Hill; Loveleen Bansi; Caroline Sabin; Andrew Phillips; David Dunn; Jane Anderson; Philippa Easterbrook; Martin Fisher; Brian Gazzard; Richard Gilson; Margaret Johnson; Clifford Leen; Chloe Orkin; Achim Schwenk; John Walsh; Alan Winston; Abdel Babiker; Valerie Delpech
Data linkage reduces loss to follow-up in an observational HIV cohort study.
Journal of clinical epidemiology 2010;63(10):1101-9.
2010: Lorraine Sherr; Fiona C Lampe; C Clucas; Margaret Johnson; Martin Fisher; H Leake Date; Jane Anderson; S Edwards; Colette J Smith; Teresa Hill; Richard Harding
Self-reported non-adherence to ART and virological outcome in a multiclinic UK study.
AIDS care 2010;22(8):939-45.
2010: Loveleen Bansi; Anna Maria Geretti; David Dunn; Teresa Hill; Hannah Green; Esther Fearnhill; Brian Gazzard; Mark Nelson; Kholoud Porter; Andrew Phillips; Caroline Sabin
Impact of transmitted drug-resistance on treatment selection and outcome of first-line Highly Active Antiretroviral Therapy (HAART).
Journal of acquired immune deficiency syndromes (1999) 2010;53(5):633-9.
2010: Caroline A Sabin; Achim Schwenk; Margaret A Johnson; Brian Gazzard; Martin Fisher; John Walsh; Chloe Orkin; Teresa Hill; Richard Gilson; Kholoud Porter; Philippa Easterbrook; Valerie Delpech; Loveleen Bansi; Clifford Leen; Mark Gompels; Jane Anderson; Andrew N Phillips
Late diagnosis in the HAART era: proposed common definitions and associations with mortality.
AIDS (London, England) 2010;24(5):723-7.
2010: R J C Gilson; S-L Man; Andrew J Copas; A Rider; S Forsyth; Teresa Hill; L Bansi; Kholoud Porter; B Gazzard; C Orkin; Deenan Pillay; A Schwenk; Margaret Johnson; P Easterbook; J Walsh; Martin Fisher; Clifford Leen; Jane Anderson; Caroline A Sabin
Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study.
HIV medicine 2010;11(2):152-60.
2010: Wolfgang Stöhr; David Back; David Dunn; Caroline Sabin; Alan Winston; Richard Gilson; Deenan Pillay; Teresa Hill; Jonathan Ainsworth; Brian Gazzard; Clifford Leen; Loveleen Bansi; Martin Fisher; Chloe Orkin; Jane Anderson; Margaret Johnson; Philippa Easterbrook; Sara Gibbons; Saye Khoo
Factors influencing lopinavir and atazanavir plasma concentration.
The Journal of antimicrobial chemotherapy 2010;65(1):129-37.
2009: Loveleen Bansi; Jo Turner; Richard Gilson; Frank Post; Brian Gazzard; Clifford Leen; Jane Anderson; Kholoud Porter; Teresa Hill; Martin Fisher; Jonathan Ainsworth; Deenan Pillay; Margaret Johnson; Alan Winston; Chloe Orkin; Philippa Easterbrook; Andrew Phillips; Caroline Sabin
Is 1 alanine transaminase >200 IU enough to define an alanine transaminase flare in HIV-infected populations? A new definition derived from a large cohort study.
Journal of acquired immune deficiency syndromes (1999) 2009;52(3):391-6.
2009: Loveleen Bansi; Caroline Sabin; Richard Gilson; Brian Gazzard; Clifford Leen; Jane Anderson; David Dunn; Teresa Hill; Martin Fisher; Jonathan Ainsworth; Deenan Pillay; Margaret Johnson; John Walsh; Chloe Orkin; Philippa Easterbrook; Mark Gompels; Andrew Phillips
Virological response to initial antiretroviral regimens containing abacavir or tenofovir.
The Journal of infectious diseases 2009;200(5):710-4.
2009: Caroline A Sabin; Colette J Smith; Valerie Delpech; Jane Anderson; L Bansi; Richard Gilson; A Schwenk; Clifford Leen; Brian Gazzard; Kholoud Porter; N Mackie; Martin Fisher; Chloe Orkin; Margaret Johnson; Philippa Easterbrook; Teresa Hill; Andrew N Phillips
The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapy.
HIV medicine 2009;10(1):35-43.
2008: Kholoud Porter; Sarah Walker; Teresa Hill; Jane Anderson; Clifford Leen; Margaret Johnson; Brian Gazzard; John Walsh; Martin Fisher; Chloe Orkin; Achim Schwenk; Richard Gilson; Philippa Easterbrook; Valerie Delpech; Caroline A Sabin
Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3.
Journal of acquired immune deficiency syndromes (1999) 2008;47(2):202-5.
2008: Loveleen K Bansi; Andrew A Benzie; Andrew N Phillips; Simon Portsmouth; Teresa Hill; Clifford Leen; Achim Schwenk; Margaret Johnson; Jane Anderson; Richard Gilson; Philippa Easterbrook; Brian Gazzard; Martin Fisher; Chloe Orkin; Kholoud Porter; Deenan Pillay; Graham P Taylor; John C Walsh; Caroline A Sabin
Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?
AIDS (London, England) 2008;22(3):349-56.
2008: Wolfgang Stöhr; David Back; David Dunn; Caroline Sabin; Alan Winston; Richard Gilson; Deenan Pillay; Teresa Hill; Jonathan Ainsworth; Anton Pozniak; Clifford Leen; Loveleen Bansi; Martin Fisher; Chloe Orkin; Jane Anderson; Margaret Johnson; Philippa Easterbrook; Sara Gibbons; Saye Khoo
Factors influencing efavirenz and nevirapine plasma concentration: effect of ethnicity, weight and co-medication.
Antiviral therapy 2008;13(5):675-85.
2008: Philippa J Easterbrook; Andrew N Phillips; Teresa Hill; Ryanne Matthias; Martin Fisher; Brian Gazzard; Richard Gilson; George Scullard; Margaret Johnson; D T Dunn; Chloe Orkin; Jane Anderson; A Schwenk; Clifford Leen; Caroline A Sabin
Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UK.
HIV medicine 2008;9(1):47-56.
2007: Andrew N Phillips; Clifford Leen; Alan Wilson; Jane Anderson; David Dunn; Achim Schwenk; Chloe Orkin; Teresa Hill; Martin Fisher; John Walsh; Deenan Pillay; Loveleen Bansi; Brian Gazzard; Philippa Easterbrook; Richard Gilson; Margaret Johnson; Caroline A Sabin
Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study.
Lancet 2007;370(9603):1923-8.
2007: Andrew N Phillips; Brian Gazzard; Richard Gilson; Philippa Easterbrook; Margaret Johnson; John Walsh; Clifford Leen; Martin Fisher; Chloe Orkin; Jane Anderson; Deenan Pillay; Valerie Delpech; Caroline Sabin; Achim Schwenk; David Dunn; Mark Gompels; Teresa Hill; Kholoud Porter; Abdel G Babiker
Rate of AIDS diseases or death in HIV-infected antiretroviral therapy-naive individuals with high CD4 cell count.
AIDS (London, England) 2007;21(13):1717-21.
2007: Andrew A Benzie; Loveleen K Bansi; Caroline A Sabin; Simon Portsmouth; Teresa Hill; Margaret Johnson; Richard Gilson; Philippa Easterbrook; Brian Gazzard; Martin Fisher; Chloe Orkin; David Dunn; Valerie Delpech; Graham P Taylor; John C Walsh; Andrew N Phillips
Increased duration of viral suppression is associated with lower viral rebound rates in patients with previous treatment failures.
AIDS (London, England) 2007;21(11):1423-30.
2007: W Stöhr; David Dunn; Kholoud Porter; Teresa Hill; Brian Gazzard; John Walsh; Richard Gilson; Philippa Easterbrook; Martin Fisher; Ma Johnson; Valerie Delpech; An Phillips; Caroline Sabin
CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997-2003.
HIV medicine 2007;8(3):135-41.
2005: Colette J Smith; Andrew N Phillips; Teresa Hill; Martin Fisher; Brian Gazzard; Kholoud Porter; Richard Gilson; Philippa Easterbrook; Ryanne Matthias; George Scullard; Margaret A Johnson; Caroline A Sabin
The rate of viral rebound after attainment of an HIV load <50 copies/mL according to specific antiretroviral drugs in use: results from a multicenter cohort study.
The Journal of infectious diseases 2005;192(8):1387-97.
2005: Caroline A Sabin; Teresa Hill; Fiona C Lampe; Ryanne Matthias; Sanjay Bhagani; Richard Gilson; Mike Youle; Margaret A Johnson; Martin Fisher; George Scullard; Philippa Easterbrook; Brian Gazzard; Andrew N Phillips
Treatment exhaustion of highly active antiretroviral therapy (HAART) among individuals infected with HIV in the United Kingdom: multicentre cohort study.
BMJ (Clinical research ed.) 2005;330(7493):695.
2005: Andrew N Phillips; David Dunn; Caroline Sabin; Anton Pozniak; Ryanne Matthias; Anna Maria Geretti; John Clarke; Duncan Churchill; Ian Williams; Teresa Hill; Hannah Green; Kholoud Porter; George Scullard; Margaret Johnson; Philippa Easterbrook; Richard Gilson; Martin Fisher; Clive Loveday; Brian Gazzard; Deenan Pillay
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice.
AIDS (London, England) 2005;19(5):487-94.